Leiv Lea | executive |
Richard Miller | executive |
Li Wang Watsek | analyst |
Jiale Song | analyst |
Aydin Huseynov | analyst |
Jeffrey Jones | analyst |
Graig Suvannavejh | analyst |
Good afternoon, everyone, and thank you for standing by. Welcome to the Corvus Pharmaceuticals Second Quarter 2024 Business Update and Financial Results Conference Call. [Operator Instructions] It is now my pleasure to turn the call over to Zack Kubow of Real Chemistry. Please go ahead, sir.
Thank you, operator, and good afternoon, everyone.